MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.4180
+0.0103 (2.53%)
At close: Jul 31, 2026, 4:00 PM EDT
0.4249
+0.0069 (1.65%)
After-hours: Jul 31, 2026, 4:42 PM EDT
MDxHealth Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 43.15 | 29.03 | 46.8 | 22.38 | 15.5 | 58.5 |
Cash & Short-Term Investments | 43.15 | 29.03 | 46.8 | 22.38 | 15.5 | 58.5 |
Cash Growth | -34.29% | -37.96% | 109.11% | 44.36% | -73.50% | 266.69% |
Accounts Receivable | 14.26 | 14.68 | 14.44 | 11.09 | 9.36 | 4.58 |
Inventory | 7.37 | 6.74 | 3.87 | 2.78 | 2.33 | 1.91 |
Other Current Assets | 3.11 | 2.96 | 1.79 | 1.91 | 1.96 | 1.62 |
Total Current Assets | 67.89 | 53.41 | 66.9 | 38.16 | 29.15 | 66.61 |
Net Property, Plant & Equipment | 13.82 | 14.68 | 12.98 | 9.95 | 7.89 | 5.02 |
Other Intangible Assets | 38.18 | 39.42 | 40.59 | 44.34 | 46.17 | 3.45 |
Goodwill | 39.3 | 38.95 | 35.93 | 35.93 | 35.93 | 0 |
Long-Term Investments | 1.65 | 1.5 | 0.94 | 0.76 | - | - |
Total Assets | 160.83 | 147.95 | 157.33 | 129.13 | 119.14 | 75.07 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 12.07 | 10.33 | 8 | 8.81 | 10.18 | 7.46 |
Accrued Expenses | 8.48 | 6.74 | 6.57 | 5.69 | 3.99 | 2.74 |
Short-Term Debt | 19.28 | 30.57 | 26.41 | 2.9 | 2.33 | 0.96 |
Current Portion of Long-Term Debt | - | - | 0.32 | 0.64 | 0.62 | 4.44 |
Current Portion of Leases | 1.75 | 1.9 | 1.36 | 1.48 | 1.17 | 0.84 |
Total Current Liabilities | 41.58 | 49.53 | 42.66 | 19.52 | 18.28 | 16.43 |
Long-Term Debt | 95.95 | 76.2 | 50.97 | 35.56 | 34.91 | 7.65 |
Long-Term Leases | 8.19 | 8.51 | 7.41 | 3.58 | 3.09 | 2.62 |
Other Long-Term Liabilities | 35.35 | 25.81 | 41.45 | 63.26 | 53.54 | 1.47 |
Total Long-Term Liabilities | 139.48 | 110.51 | 99.83 | 102.4 | 91.54 | 11.74 |
Total Liabilities | 181.06 | 160.05 | 142.49 | 121.92 | 109.82 | 28.17 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 219.21 | 219.21 | 214.67 | 173.93 | 133.45 | 128.45 |
Additional Paid-in Capital | 173.07 | 172.51 | 170.3 | 165.32 | 164.65 | 163.78 |
Accumulated Other Comprehensive Income | -0.61 | -0.78 | -0.62 | -0.59 | -0.44 | -1.04 |
Retained Earnings | -411.9 | -403.03 | -369.52 | -331.45 | -288.35 | -244.3 |
Shareholders' Equity | -20.23 | -12.09 | 14.84 | 7.21 | 9.32 | 46.9 |
Total Liabilities & Equity | 160.83 | 147.95 | 157.33 | 129.13 | 119.14 | 75.07 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 125.17 | 117.17 | 86.48 | 44.16 | 42.12 | 16.52 |
Net Cash (Debt) | -82.01 | -88.14 | -39.68 | -21.78 | -26.62 | 41.98 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.61 | -1.76 | -1.21 | -0.84 | -1.68 | 3.44 |
Book Value | -20.23 | -12.09 | 14.84 | 7.21 | 9.32 | 46.9 |
Book Value Per Share | -0.40 | -0.24 | 0.45 | 0.28 | 0.59 | 3.85 |
Tangible Book Value | -97.7 | -90.47 | -61.68 | -73.06 | -72.78 | 43.45 |
Tangible Book Value Per Share | -1.91 | -1.81 | -1.88 | -2.82 | -4.59 | 3.56 |